Published in J Psychiatry Neurosci on January 01, 2003
Testing assumptions for endophenotype studies in ADHD: reliability and validity of tasks in a general population sample. BMC Psychiatry (2005) 1.41
What causes attention deficit hyperactivity disorder? Arch Dis Child (2011) 1.24
The neural and genetic basis of executive function: attention, cognitive flexibility, and response inhibition. Pharmacol Biochem Behav (2013) 1.11
Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD. J Psychiatry Neurosci (2008) 1.10
Temperament and its role in developmental psychopathology. Harv Rev Psychiatry (2005) 1.08
Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders. J Neurochem (2013) 1.05
Early life protein restriction alters dopamine circuitry. Neuroscience (2010) 1.04
Neurological correlates of reward responding in adolescents with and without externalizing behavior disorders. J Abnorm Psychol (2009) 0.99
The association between creativity and 7R polymorphism in the dopamine receptor D4 gene (DRD4). Front Hum Neurosci (2013) 0.99
Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors. J Psychopharmacol (2009) 0.99
Fitting the pieces together: current research on the genetic basis of attention-deficit/hyperactivity disorder (ADHD). Neuropsychiatr Dis Treat (2010) 0.95
Neuregulin and dopamine modulation of hippocampal gamma oscillations is dependent on dopamine D4 receptors. Proc Natl Acad Sci U S A (2012) 0.91
Genetic aspects in attention-deficit/hyperactivity disorder. J Neural Transm (Vienna) (2008) 0.90
D1 and D2 dopamine receptor-mediated inhibition of activated normal T cell proliferation is lost in jurkat T leukemic cells. J Biol Chem (2010) 0.90
How central is dopamine to pathological gambling or gambling disorder? Front Behav Neurosci (2013) 0.87
Motor timing deficits in children with Attention-Deficit/Hyperactivity disorder. Hum Mov Sci (2011) 0.87
Twin studies and their implications for molecular genetic studies: endophenotypes integrate quantitative and molecular genetics in ADHD research. J Am Acad Child Adolesc Psychiatry (2010) 0.86
Potential contribution of dopaminergic gene variants in ADHD core traits and co-morbidity: a study on eastern Indian probands. Cell Mol Neurobiol (2014) 0.86
A dopamine receptor (DRD2) but not dopamine transporter (DAT1) gene polymorphism is associated with neurocognitive development of Mexican preschool children with lead exposure. J Pediatr (2011) 0.84
Fundamental movement skills and children with attention-deficit hyperactivity disorder: peer comparisons and stimulant effects. J Abnorm Child Psychol (2007) 0.83
Epigenetics in Developmental Disorder: ADHD and Endophenotypes. J Genet Syndr Gene Ther (2011) 0.81
Attention deficit and hyperactivity disorder among school children in Kinshasa, Democratic Republic of Congo. Afr Health Sci (2005) 0.80
Genetics of developmental psychiatric disorders: pathways to discovery. J Psychiatry Neurosci (2005) 0.79
The impact of cafeteria diet feeding on physiology and anxiety-related behaviour in male and female Sprague-Dawley rats of different ages. Pharmacol Biochem Behav (2013) 0.78
Attention Deficit/Hyperactivity Disorder and Urinary Nonylphenol Levels: A Case-Control Study in Taiwanese Children. PLoS One (2016) 0.76
Hardy-Weinberg equilibrium analysis of the 48 bp VNTR in the III exon of the DRD4 gene in a sample of parents of ADHD cases. Appl Clin Genet (2015) 0.76
An Overview on the Genetics of ADHD. Xin Li Xue Bao (2008) 0.75
Catecholaminergic gene variants: contribution in ADHD and associated comorbid attributes in the eastern Indian probands. Biomed Res Int (2013) 0.75
Retracted Association of Catechol-O-methyltransferase val/met polymorphism with cognitive function in Gilles de la Tourette syndrome patients. Neurol Sci (2014) 0.75
The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet (1995) 24.52
Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet (1987) 13.98
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A (2001) 9.42
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature (1996) 7.26
Linkage disequilibrium mapping of complex disease: fantasy or reality? Curr Opin Biotechnol (1998) 5.36
Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry (1991) 5.35
Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet (1998) 5.34
Multiple dopamine D4 receptor variants in the human population. Nature (1992) 4.08
Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A (1998) 3.99
Epidemiology of ADHD in school-age children. Child Adolesc Psychiatr Clin N Am (2000) 3.25
Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry (2001) 3.16
Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem (1995) 3.08
D(1) receptors in prefrontal cells and circuits. Brain Res Brain Res Rev (2000) 2.95
Tests and estimates of allelic association in complex inheritance. Proc Natl Acad Sci U S A (1998) 2.78
Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics (2001) 2.59
Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics (1992) 2.55
Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet (1995) 2.54
Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry (1996) 2.49
A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus. Hum Genet (1998) 2.44
Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature (1995) 2.37
Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet (1992) 2.32
Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology (2000) 2.28
Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology (1997) 2.21
Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci (2000) 2.18
The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus. Hum Genet (1996) 2.13
Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry (1999) 2.11
Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell (1994) 2.05
Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. J Am Acad Child Adolesc Psychiatry (1999) 1.88
Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell (1997) 1.83
Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry (1998) 1.82
Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol (1992) 1.76
Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet (1998) 1.75
Linkage of a gene regulating dopamine-beta-hydroxylase activity and the ABO blood group locus. Am J Hum Genet (1988) 1.69
Toward a pathophysiology of attention-deficit/hyperactivity disorder. Clin Pediatr (Phila) (1997) 1.66
A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet (2002) 1.63
Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem (1994) 1.62
Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry (1999) 1.59
Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Mol Psychiatry (1998) 1.55
Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry (2000) 1.54
Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. Proc Natl Acad Sci U S A (2000) 1.53
Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet (1996) 1.49
Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1----q11.2. Genomics (1992) 1.49
A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci U S A (1996) 1.48
Families of children with attention deficit hyperactivity disorder: a review. Can J Psychiatry (1996) 1.47
Dopamine genes and ADHD. Neurosci Biobehav Rev (2000) 1.46
Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. Cytogenet Cell Genet (1988) 1.44
Lack of an association between a dopamine-4 receptor polymorphism and attention-deficit/hyperactivity disorder: genetic and brain morphometric analyses. Mol Psychiatry (1998) 1.41
Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample. J Dev Behav Pediatr (1998) 1.39
Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry (2002) 1.37
Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol Psychiatry (1998) 1.32
Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD). Mol Psychiatry (2000) 1.30
The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology (2001) 1.28
The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J Neurochem (2001) 1.27
Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system. Biochem Biophys Res Commun (1996) 1.25
Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1. Am J Med Genet (1996) 1.24
Cloning, expression and structure of catechol-O-methyltransferase. Biochim Biophys Acta (1995) 1.24
Are perinatal complications relevant to the manifestation of ADD? Issues of comorbidity and familiality. J Am Acad Child Adolesc Psychiatry (1993) 1.23
Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Mol Psychiatry (1998) 1.21
Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. Am J Med Genet (1999) 1.17
A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder. Mol Psychiatry (2000) 1.16
Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants. Pharmacogenetics (1999) 1.16
Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes. Mol Pharmacol (1994) 1.14
Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Mol Psychiatry (2000) 1.12
High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder. Am J Psychiatry (1999) 1.11
VNTR (variable number of tandem repeat) sequences as transcriptional, translational, or functional regulators. J Hum Genet (1998) 1.10
A serine to glycine substitution at position 9 in the extracellular N-terminal part of the dopamine D3 receptor protein: no role in the genetic predisposition to bipolar affective disorder. Psychiatry Res (1993) 1.10
Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders. Am J Hum Genet (1997) 1.08
Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet (1999) 1.06
Dopamine D4 receptor gene: novelty or nonsense? Neuropsychopharmacology (1999) 1.05
Stress as a mediating factor in the association between the DRD2 TaqI polymorphism and alcoholism. Alcohol (2001) 1.03
Working memory in childhood-onset schizophrenia and attention-deficit/hyperactivity disorder. Psychiatry Res (1998) 1.03
Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am J Med Genet (2001) 1.02
Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder. Biol Psychiatry (2001) 1.01
Tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4). Am J Med Genet (1999) 1.00
Relationship between two-year behaviour and neurodevelopmental outcome at five years of very low-birthweight survivors. Dev Med Child Neurol (1987) 0.99
Pregnancy, delivery and infancy complications and attention deficit hyperactivity disorder: issues of gene-environment interaction. Biol Psychiatry (1997) 0.98
Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene. Am J Med Genet (2002) 0.98
The diagnosis and prevalence of hyperactivity in Chinese schoolboys. Br J Psychiatry (1996) 0.97
Clinical and molecular genetics of ADHD and Tourette syndrome. Two related polygenic disorders. Ann N Y Acad Sci (2001) 0.97
Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Am J Psychiatry (1999) 0.94
Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mol Psychiatry (2001) 0.94
Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study. Am J Med Genet (2001) 0.93
Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacy. Arch Gen Psychiatry (1985) 0.93
Linkage study of catechol-O-methyltransferase and attention-deficit hyperactivity disorder. Am J Med Genet (1999) 0.92
Attention deficit hyperactivity disorder (ADHD) and the dopamine D4 receptor gene: evidence of association but no linkage in a UK sample. Mol Psychiatry (2001) 0.92
Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes. Clin Genet (2000) 0.91
No association between catechol-O-methyltransferase (COMT) gene polymorphism and attention deficit hyperactivity disorder (ADHD) in an Irish sample. Am J Med Genet (2000) 0.91
No evidence of linkage or linkage disequilibrium between DAT1 and attention deficit hyperactivity disorder in a large sample. Psychiatr Genet (1999) 0.90
5'-untranslated region of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Am J Med Genet (2001) 0.89
Failure to replicate an excess of the long dopamine D4 exon III repeat polymorphism in ADHD in a family-based study. Am J Med Genet (2000) 0.89
No association of the dopamine DRD4 receptor (DRD4) gene polymorphism with attention deficit hyperactivity disorder (ADHD) in the Irish population. Am J Med Genet (2000) 0.88
Further evidence from haplotype analysis for linkage of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Am J Med Genet (2000) 0.87
Why different rules are required for polygenic inheritance: lessons from studies of the DRD2 gene. Alcohol (1998) 0.87
Adult attention deficit hyperactivity disorder and the dopamine D4 receptor gene. Am J Med Genet (2000) 0.86
Functional analysis of the human D5 dopamine receptor missense and nonsense variants: differences in dopamine binding affinities. Pharmacogenetics (1999) 0.86
The D2 dopamine receptor (DRD2) gene and family stress; interactive effects on cognitive functions in children. Behav Genet (1997) 0.86
A transmission disequilibrium test of the Ser9/Gly dopamine D3 receptor gene polymorphism in adult attention-deficit hyperactivity disorder. Behav Brain Res (2002) 0.86
No association of the dopamine transporter gene 3' VNTR polymorphism with ADHD subtypes in a population sample of twins. Am J Med Genet (2001) 0.85
Chromosomal localization of the human D3 dopamine receptor gene. Hum Genet (1991) 0.85
Linkage study of two polymorphisms at the dopamine D3 receptor gene and attention-deficit hyperactivity disorder. Am J Med Genet (2000) 0.84
Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet (2011) 4.01
Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med (2009) 3.88
Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet (2010) 3.69
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A (2010) 3.13
Novel de novo SHANK3 mutation in autistic patients. Am J Med Genet B Neuropsychiatr Genet (2009) 2.43
Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet (2011) 1.94
De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. Am J Hum Genet (2010) 1.79
Functional magnetic resonance imaging correlates of memory encoding in relation to achieving remission in first-episode schizophrenia. Br J Psychiatry (2012) 1.70
Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum Mol Genet (2008) 1.66
Effects of methylphenidate on acute math performance in children with attention-deficit hyperactivity disorder. Can J Psychiatry (2013) 1.61
NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population. Am J Med Genet B Neuropsychiatr Genet (2005) 1.60
Intranasal oxytocin impedes the ability to ignore task-irrelevant facial expressions of sadness in students with depressive symptoms. Psychoneuroendocrinology (2012) 1.42
Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry (2002) 1.37
Informative phenotypes for genetic studies of psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet (2007) 1.35
De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiatry (2011) 1.25
Perinatal complications in children with attention-deficit hyperactivity disorder and their unaffected siblings. J Psychiatry Neurosci (2005) 1.18
First-episode psychosis, early intervention, and outcome: what have we learned? Can J Psychiatry (2005) 1.18
Molecular cloning and characterization of human RAI1, a gene associated with schizophrenia. Genomics (2003) 1.17
Determinants of help-seeking and system related components of delay in the treatment of first-episode psychosis. Schizophr Res (2007) 1.14
Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J Psychiatr Res (2004) 1.13
Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD. J Psychiatry Neurosci (2008) 1.10
Is the inattentive subtype of ADHD different from the combined/hyperactive subtype? J Atten Disord (2009) 1.09
Candidate genes and neuropsychological phenotypes in children with ADHD: review of association studies. J Psychiatry Neurosci (2009) 1.07
Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: a randomized crossover trial. J Psychiatry Neurosci (2006) 1.07
The 5HTTLPR polymorphism, psychopathologic symptoms, and platelet [3H-] paroxetine binding in bulimic syndromes. Int J Eat Disord (2005) 1.07
Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls? Schizophr Res (2008) 1.06
Serotonin-system polymorphisms (5-HTTLPR and -1438G/A) and responses of patients with bulimic syndromes to multimodal treatments. J Clin Psychiatry (2008) 1.05
Intranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study. Psychoneuroendocrinology (2012) 1.05
Neuropsychological endophenotypes in attention-deficit/hyperactivity disorder: a review of genetic association studies. Eur Arch Psychiatry Clin Neurosci (2011) 1.04
Mutation screening of FOXP2 in individuals diagnosed with autistic disorder. Am J Med Genet A (2003) 1.03
Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD. BMC Psychiatry (2011) 1.02
The acute effects of intranasal oxytocin on automatic and effortful attentional shifting to emotional faces. Psychophysiology (2011) 1.02
Education modulates cortisol reactivity to the Trier Social Stress Test in middle-aged adults. Psychoneuroendocrinology (2007) 1.01
The relative contribution of cognition and symptomatic remission to functional outcome following treatment of a first episode of psychosis. J Clin Psychiatry (2014) 0.99
A comparison study of multiple measures of adherence to antipsychotic medication in first-episode psychosis. J Clin Psychopharmacol (2010) 0.99
Effectiveness of a therapeutic summer camp for children with ADHD: Phase I Clinical Intervention Trial. J Atten Disord (2011) 0.97
Selective abnormal modulation of hippocampal activity during memory formation in first-episode psychosis. Arch Gen Psychiatry (2007) 0.97
Duration of untreated psychosis is associated with orbital-frontal grey matter volume reductions in first episode psychosis. Schizophr Res (2010) 0.96
Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls. Schizophr Res (2011) 0.96
Fronto-temporal disconnectivity and clinical short-term outcome in first episode psychosis: a DTI-tractography study. J Psychiatr Res (2010) 0.96
Cognitive insight and verbal memory in first episode of psychosis. Eur Psychiatry (2008) 0.94
Association of trait-defined, eating-disorder sub-phenotypes with (biallelic and triallelic) 5HTTLPR variations. J Psychiatr Res (2009) 0.93
Development and persistence of posttraumatic stress disorder and the 5-HTTLPR polymorphism. J Trauma Stress (2009) 0.93
Maternal smoking during pregnancy and ADHD: a comprehensive clinical and neurocognitive characterization. Nicotine Tob Res (2012) 0.91
Publication bias: what are the challenges and can they be overcome? J Psychiatry Neurosci (2012) 0.91
Association between 7q31 markers and Tourette syndrome. Am J Med Genet A (2004) 0.90
Performance on the continuous performance test in children with ADHD is associated with sleep efficiency. Sleep (2007) 0.90
Serotonin transporter, stressful life events, and depression severity. Am J Psychiatry (2007) 0.90
Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: a genetic association study. Am J Med Genet B Neuropsychiatr Genet (2003) 0.90
Early intervention for psychosis: a Canadian perspective. J Nerv Ment Dis (2015) 0.90
Association of the promoter polymorphism -1438G/A of the 5-HT2A receptor gene with behavioral impulsiveness and serotonin function in women with bulimia nervosa. Am J Med Genet B Neuropsychiatr Genet (2005) 0.89
Understanding putative risk factors for schizophrenia: retrospective and prospective studies. J Psychiatry Neurosci (2005) 0.88
The 5HTTLPR polymorphism, prior maltreatment and dramatic-erratic personality manifestations in women with bulimic syndromes. J Psychiatry Neurosci (2007) 0.88
Intrafamilial correspondences on platelet [3H-]paroxetine-binding indices in bulimic probands and their unaffected first-degree relatives. Neuropsychopharmacology (2006) 0.88
LPHN3 and attention-deficit/hyperactivity disorder: interaction with maternal stress during pregnancy. J Child Psychol Psychiatry (2012) 0.87
Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly. J Med Genet (2013) 0.87
The structural neural substrates of persistent negative symptoms in first-episode of non-affective psychosis: a voxel-based morphometry study. Front Psychiatry (2012) 0.87
Maternal Stress during Pregnancy, ADHD Symptomatology in Children and Genotype: Gene-Environment Interaction. J Can Acad Child Adolesc Psychiatry (2012) 0.87
The parahippocampal gyrus as a neural marker of early remission in first-episode psychosis: a voxel-based morphometry study. Clin Schizophr Relat Psychoses (2011) 0.87
Differential effects of adrenergic and corticosteroid hormonal systems on human short- and long-term declarative memory for emotionally arousing material. Behav Neurosci (2004) 0.87
Identifying persistent negative symptoms in first episode psychosis. BMC Psychiatry (2012) 0.87
Cognitive markers of short-term clinical outcome in first-episode psychosis. Br J Psychiatry (2008) 0.87
Childhood trauma and dissociation in first-episode psychosis, chronic schizophrenia and community controls. Psychiatry Res (2013) 0.86
Family-based association study of ADHD and genes increasing the risk for smoking behaviours. Arch Dis Child (2012) 0.86
Intranasal oxytocin and salivary cortisol concentrations during social rejection in university students. Stress (2011) 0.86
Case manager- and patient-rated alliance as a predictor of medication adherence in first-episode psychosis. J Clin Psychopharmacol (2012) 0.86
Actigraphic monitoring during sleep of children with ADHD on methylphenidate and placebo. J Am Acad Child Adolesc Psychiatry (2004) 0.86
Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders. Can J Psychiatry (2010) 0.86
Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2009) 0.85
Relevance of the 5-HTTLPR polymorphism and childhood abuse to increased psychiatric comorbidity in women with bulimia-spectrum disorders. J Clin Psychiatry (2008) 0.85
Catechol-O-methyltransferase (COMT) Val108/158 Met polymorphism does not modulate executive function in children with ADHD. BMC Med Genet (2004) 0.85
No association between the DRD3 Ser9Gly polymorphism and schizophrenia. Schizophr Res (2007) 0.85
Disrupted integrity of the fornix in first-episode schizophrenia. Schizophr Res (2010) 0.85
Methylation of the dopamine D2 receptor (DRD2) gene promoter in women with a bulimia-spectrum disorder: associations with borderline personality disorder and exposure to childhood abuse. J Psychiatr Res (2013) 0.84
Schizotypy, attention deficit hyperactivity disorder, and dopamine genes. Psychiatry Clin Neurosci (2006) 0.84
Association between schizophrenia and genetic variation in DCC: a case-control study. Schizophr Res (2012) 0.84
Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis. Can J Psychiatry (2009) 0.84
COMT Val108/158Met gene variant, birth weight, and conduct disorder in children with ADHD. J Am Acad Child Adolesc Psychiatry (2006) 0.84
Physical activity experiences of boys with and without ADHD. Adapt Phys Activ Q (2009) 0.84
Cortical thickness is associated with poor insight in first-episode psychosis. J Psychiatr Res (2010) 0.84
The effects of glucocorticoids on the inhibition of emotional information: A dose-response study. Biol Psychol (2010) 0.83
Sensitivity of scales to evaluate change in symptomatology with psychostimulants in different ADHD subtypes. J Can Acad Child Adolesc Psychiatry (2013) 0.83
Fundamental movement skills and children with attention-deficit hyperactivity disorder: peer comparisons and stimulant effects. J Abnorm Child Psychol (2007) 0.83
Coping style moderates the effect of intranasal oxytocin on the mood response to interpersonal stress. Exp Clin Psychopharmacol (2011) 0.83
The 5-HTTLPR polymorphism of the serotonin transporter gene and short term behavioral response to methylphenidate in children with ADHD. BMC Psychiatry (2010) 0.83
Sensitivity of tests to assess improvement in ADHD symptomatology. Can Child Adolesc Psychiatr Rev (2004) 0.83
Declarative memory after stress in humans: differential involvement of the beta-adrenergic and corticosteroid systems. J Clin Endocrinol Metab (2004) 0.83
Diagnostic stability of first-episode psychotic disorders and persistence of comorbid psychiatric disorders over 1 year. Can J Psychiatry (2013) 0.83
Relationship between response to methylphenidate treatment in children with ADHD and psychopathology in their families. J Am Acad Child Adolesc Psychiatry (2006) 0.82
Is there an association between neurocognitive performance and medication adherence in first episode psychosis? Early Interv Psychiatry (2010) 0.82
Comprehensive phenotype/genotype analyses of the norepinephrine transporter gene (SLC6A2) in ADHD: relation to maternal smoking during pregnancy. PLoS One (2012) 0.82
Acute and long-term associations between ApoE genetic polymorphism, cortisol levels, and declarative memory performance in older adults. Psychoneuroendocrinology (2008) 0.82
Validation of the English and French versions of the Community Assessment of Psychic Experiences (CAPE) with a Montreal community sample. Schizophr Res (2007) 0.82
Dopamine transporter 3'UTR VNTR genotype is a marker of performance on executive function tasks in children with ADHD. BMC Psychiatry (2008) 0.82
Body weight and ADHD: examining the role of self-regulation. PLoS One (2013) 0.82
CAA insertion polymorphism in the 3'UTR of Nogo gene on 2p14 is not associated with schizophrenia. Brain Res Mol Brain Res (2005) 0.82
Sleep and COMT polymorphism in ADHD children: preliminary actigraphic data. J Am Acad Child Adolesc Psychiatry (2006) 0.82
Weight gain and lipid metabolic abnormalities induced by olanzapine in first-episode, drug-naïve patients with psychotic disorders. Schizophr Res (2005) 0.82
Association between obesity-related gene FTO and ADHD. Obesity (Silver Spring) (2013) 0.82